Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DBT Capital is a Stockholm-based financial technology company that provides growth capital and corporate lending solutions to small and medium-sized enterprises (SMEs). The company leverages a proprietary data-driven credit assessment platform to offer flexible and transparent financing, bridging the funding gap often left by traditional banks. While not a life sciences company itself, DBT Capital frequently provides essential growth funding to scaling companies across various sectors, including healthcare and biotechnology. Their services are designed to support innovation and expansion for established businesses with proven business models.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DBT Capital.